Adalimumab-Induced Erythrodermic Psoriasis Associated with Alopecia in a Patient with Palmoplantar Pustulosis

In recent years, with the increased usage of tumour necrosis factor (TNF) inhibitors, more side effects have been revealed. Paradoxical psoriasis, including psoriasis vulgaris, palmoplantar pustulosis, scalp psoriasis and their combinations, is a common adverse effect. However, erythrodermic psorias...

Full description

Bibliographic Details
Published in:	Indian Journal of Dermatology
Main Authors:	Ying Wang, Yong Cui, Zhancai Zheng
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-04-01
Subjects:	adalimumab alopecia erythrodermic psoriasis
Online Access:	https://journals.lww.com/10.4103/ijd.ijd_155_23

Similar Items

Efficacy and Safety of Adalimumab and Secukinumab in Erythrodermic Psoriasis: A Single Centre Retrospective Study
by: Yachen Wang, et al.
Published: (2025-07-01)

Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up
by: Song B, et al.
Published: (2024-08-01)

Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series
by: Andrea D'Arino, et al.
Published: (2025-07-01)

A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab
by: Megna M, et al.
Published: (2023-12-01)

Erythrodermic Psoriasis Managed with Risankizumab
by: Abdulmajeed Alajlan, et al.
Published: (2022-08-01)

A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab [Corrigendum]
by: Megna M, et al.
Published: (2024-06-01)

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
by: Potestio L, et al.
Published: (2023-08-01)

Bullous Pemphigoid Associated with Erythrodermic Psoriasis: A Case Report
by: Chen W, et al.
Published: (2022-09-01)

SAPHO Syndrome with Palmoplantar Pustulosis as the First Manifestation Successfully Treated with Adalimumab
by: Yang Q, et al.
Published: (2022-11-01)

A nomogram diagnostic cardiovascular disease in patients with erythrodermic psoriasis in Chinese
by: Yue-Min Zou, et al.
Published: (2023-06-01)

Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report
by: Lu X, et al.
Published: (2023-07-01)

Erythrodermic Psoriasis with Superimposed Fungal Infection-a Presentation in the Emergency Room
by: Muhammad Akbar Baig, et al.
Published: (2018-03-01)

Biologic anti-IL17 drugs in erythrodermic psoriasisCapsule Summary
by: Alessandro Falco, MD, et al.
Published: (2024-09-01)

Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
by: Rosita Saraceno, et al.
Published: (2013-09-01)

Efficacy and Safety of Oxymatrine in the Treatment of Patients with Erythrodermic Psoriasis
by: Huijuan Shi, et al.
Published: (2024-05-01)

Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Respiratory Distress Syndrome Associated with Erythrodermic Psoriasis
by: Lamya Noure, et al.
Published: (2021-02-01)

Efficacy and safety of biologics in erythrodermic psoriasis: a systematic review and single-arm meta-analysis
by: Lingjie Gao, et al.
Published: (2025-10-01)

Ustekinumab is effective and safe in the long‐term treatment of erythrodermic psoriasis: Multicenter study in daily practice
by: Clara Plana, et al.
Published: (2024-06-01)

Prevalence of Metabolic Syndrome in Chinese Patients With Erythrodermic Psoriasis: A Case-Control Study
by: An-ran Ma, et al.
Published: (2021-12-01)

Heart failure in erythrodermic psoriasis: a retrospective study of 225 patients
by: Chao Wu, et al.
Published: (2023-08-01)

Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
by: Aya Fadel, et al.
Published: (2025-06-01)

Unilateral Verrucous Psoriasis Successfully Treated With Adalimumab
by: Artur Antônio Duarte, et al.
Published: (2024-01-01)

Efficacy and Safety of Bimekizumab in Japanese Patients with Generalised Pustular Psoriasis and Erythrodermic Psoriasis: 3-Year Results from BE BRIGHT, a Multicentre, Open-Label, Phase 3 Study
by: Yukari Okubo, et al.
Published: (2025-08-01)

Update on Erythrodermic Psoriasis: Proposal of a Management Algorithm by an Innovative Severity Evaluation Approach
by: Xu JM, et al.
Published: (2025-07-01)

Possible effects of anti-interleukin-17 agents on erythrodermic psoriasis with thymoma: A case report
by: Qiuyu Jia, MD, PhD, et al.
Published: (2025-10-01)

Diffuse large B-cell lymphoma that develops after adalimumab using adalimumab in a patient with psoriasis
by: Esra Yıldırım Bay, et al.
Published: (2021-06-01)

Adalimumab in Recalcitrant Severe Psoriasis Associated with Atopic Dermatitis
by: Savas Yayli, et al.
Published: (2013-11-01)

Adalimumab induced psoriasis in a Crohn’s disease patient: a case report
by: Dhaifallah Alrakawi Alenizi
Published: (2024-06-01)

Successful Treatment with Secukinumab in an Erythrodermic Psoriasis Patient with End-Stage Kidney Disease on Hemodialysis: A Case Report
by: Zhang S, et al.
Published: (2025-10-01)

Dupilumab‐Induced Erythrodermic Psoriasiform Dermatitis in Chronic Actinic Dermatitis: Case Report and Innovative Treatment Approach
by: Joe Khodeir, et al.
Published: (2024-11-01)

Onychoscopy in Palmoplantar Psoriasis: A Comparative Study of Nonpustular Palmoplantar Psoriasis and Palmoplantar Pustulosis
by: Ahu Yorulmaz
Published: (2024-10-01)

Effectiveness, quality of life, and safety of secukinumab versus conventional systemic therapy in patients with erythrodermic psoriasis: a comparative study
by: Ying Zhou, et al.
Published: (2024-11-01)

Efficacy and safety of cyclosporin, adalimumab and secukinumab in the treatment of nail psoriasis
by: Zhanhan TANG, et al.
Published: (2023-04-01)

Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab
by: Angela Fico, et al.
Published: (2025-05-01)

Lithium-Associated Generalized Ostraceous Psoriasis Treated with Adalimumab: A Case Report
by: Yang Y, et al.
Published: (2023-04-01)

Adalimumab
by: Nilgun Atakan
Published: (2022-04-01)

Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis
by: Zhang C, et al.
Published: (2023-10-01)

Transition from secukinumab to adalimumab in COVID‐19‐induced psoriasis flare‐up treatment: A case report
by: Yuting Chen, et al.
Published: (2023-10-01)

HLA-DR Helps to Differentiate Erythrodermic Cutaneous T-cell Lymphoma from Erythrodermic Inflammatory Dermatoses in Flow Cytometry
by: Jingru Sun, et al.
Published: (2023-08-01)